Recombinant Chicken KCNG2 (potassium voltage-gated channel subfamily G member 2) is a lab-produced protein corresponding to the chicken ortholog of the human KCNG2 gene. This ion channel subunit belongs to the voltage-gated potassium (Kv) channel family, specifically the Kv6 subfamily, and functions as a gamma subunit in heteromeric complexes. Its primary roles include regulating cardiac action potential repolarization, neuronal excitability, and electrolyte transport in epithelial tissues .
Gene Orthologs: Identified in chicken (GenBank ID: 395902), human (26251), mouse (240444), and other species .
Protein Structure: Full-length chicken KCNG2 spans 518 amino acids (aa), with a predicted molecular weight of ~51.2 kDa .
Recombinant KCNG2 is synthesized via bacterial (E. coli) or mammalian (HEK293) expression systems, with tags (e.g., His-tag) for purification.
Channel Activity: Contributes to delayed rectifier potassium currents, critical for cardiac repolarization .
Tissue Expression: High expression reported in chicken heart, liver, skeletal muscle, kidney, and pancreas .
Recombinant KCNG2 is instrumental in studying ion channel biophysics and pathophysiology.
KCNG2 interacts with other potassium channels (e.g., KCNA5, KCNG3) and participates in pathways like:
Potassium Ion Transport: Modulates electrolyte balance in epithelial cells .
Neuronal Signaling: Regulates neurotransmitter release and excitability .
| Protein | Interaction Type |
|---|---|
| KCNA5 | Co-assembly in Kv channel complexes |
| KCNG3 | Heteromerization for functional diversity |
| KCNC1 | Modulation of channel gating kinetics |
Commercial sources offer diverse recombinant KCNG2 variants tailored for specific research needs:
| Product | Source | Tag | Host System | Key Feature |
|---|---|---|---|---|
| RFL21577GF | Chicken | His | E. coli | Full-length (1–518 aa), >90% purity |
| KCNG2-2836R | Rat | Avi/Fc/His | HEK293 | Pre-coupled magnetic beads for IP |
| KCNG2-3180R | Rat | His | Mammalian | Cardiac research focus |
Functional Studies: Limited data on chicken KCNG2’s role in disease models (e.g., cardiac arrhythmias).
Structural Insights: Cryo-EM or crystallography studies required to resolve conformational dynamics.
Antibody Validation: Cross-reactivity of anti-KCNG2 antibodies across species remains understudied .
Potassium voltage-gated channels, including those in the G subfamily, typically contain 6 transmembrane segments (S1-S6) with a voltage-sensor domain located in S4. This structural arrangement is similar to what has been documented in other voltage-gated potassium channels such as KCNB2 (Kv2.2) . The functional channels form as tetramers, either as homotetramers (four identical subunits) or heterotetramers (combinations with other alpha subunits). In chicken models, these channels maintain the conserved structure seen across species, with channel-specific variations in the intracellular domains that likely regulate channel-specific functions and interactions.
While specific expression data for chicken KCNG2 is not extensively documented in the provided search results, voltage-gated potassium channels in the same superfamily show tissue-specific distribution patterns. Based on studies of related channels like KCNB2, which is primarily expressed in brain and smooth muscle cells , we can infer that KCNG2 likely shows predominant expression in excitable tissues such as neurons, cardiac cells, and possibly specific smooth muscle types in chickens. Researchers should conduct tissue-specific RT-PCR or immunohistochemistry to precisely map KCNG2 expression across chicken tissues for their specific research questions.
The optimal approach for cloning and expressing recombinant chicken KCNG2 involves a multistep process:
RNA Extraction and cDNA Synthesis: Extract total RNA from chicken tissues with high KCNG2 expression (likely brain tissue). Use oligo(dT) primers and reverse transcriptase to synthesize cDNA.
PCR Amplification: Design specific primers based on the chicken KCNG2 sequence, incorporating appropriate restriction sites for subsequent cloning.
Vector Selection: Choose an expression vector appropriate for your experimental system. For mammalian cell expression, vectors with CMV promoters (e.g., pcDNA3.1) are recommended. For bacterial expression, pET vectors may be suitable for generating protein for antibody production.
Expression System Selection: For functional studies, mammalian expression systems (HEK293, CHO) are preferred as they provide appropriate post-translational modifications and cellular machinery for proper channel folding and trafficking.
Verification: Confirm the cloned sequence by DNA sequencing before proceeding to expression studies.
The methodology should be adapted from established protocols used for other voltage-gated potassium channels, with specific modifications for the chicken KCNG2 sequence characteristics.
For characterizing chicken KCNG2 channel properties, several electrophysiological techniques are recommended:
Patch-Clamp Recordings: Whole-cell patch-clamp technique is the gold standard for characterizing voltage-gated ion channels. This allows measurement of:
Activation and inactivation kinetics
Voltage-dependence of activation and inactivation
Current density
Single-channel conductance (using single-channel recording configurations)
Voltage-Clamp Protocols: Implement step-voltage protocols from holding potentials of -80 to -100 mV, with test pulses ranging from -100 to +60 mV to fully characterize voltage-dependence.
Current-Clamp Recordings: To assess the contribution of KCNG2 to action potential characteristics in excitable cells.
Heterologous Expression Systems: Use systems like Xenopus oocytes or HEK293 cells transfected with chicken KCNG2 to isolate channel function from other cellular components.
Pharmacological Profiling: Apply known potassium channel blockers (TEA, 4-AP, etc.) to determine sensitivity profiles specific to chicken KCNG2.
Documentation of the biophysical properties should include detailed tables of activation/inactivation parameters and comparative analyses with mammalian KCNG2 homologs to highlight species-specific differences.
Developing specific antibodies against chicken KCNG2 requires careful antigen design and validation:
Antigen Selection: Choose unique epitopes from the chicken KCNG2 sequence, preferably from extracellular domains or unique intracellular regions with low homology to other potassium channels. The C-terminus often provides good antigenic regions for channel proteins.
Peptide Synthesis vs. Recombinant Protein: For shorter epitopes (10-20 amino acids), synthesized peptides conjugated to carrier proteins (KLH or BSA) can be used. For larger regions, express recombinant protein fragments in bacterial systems.
Immunization Protocol: Implement a standard immunization protocol using rabbits for polyclonal antibodies or mice for monoclonal antibody development. For monoclonal antibodies, follow with hybridoma technology.
Antibody Purification: Use affinity chromatography with the immunizing antigen to obtain highly specific antibodies.
Validation Methods:
Western blotting against recombinant KCNG2 and tissue lysates
Immunohistochemistry on chicken tissues with known expression
Comparative analysis in KCNG2 knockout or knockdown systems
Pre-absorption controls with immunizing peptide
Cross-reactivity testing against related potassium channels
Proper validation is critical as many ion channel antibodies show cross-reactivity with related family members, potentially leading to misinterpretation of experimental results.
Heteromeric assemblies of potassium channels can significantly alter their functional properties. For chicken KCNG2:
Potential Assembly Partners: KCNG2 may form heteromeric channels with other members of the voltage-gated potassium channel family, particularly those in the same subfamily or closely related ones. By analogy with KCNB2 (Kv2.2), which can form heterotetrameric channels with other alpha subunits , KCNG2 likely exhibits similar capabilities.
Methodological Approach:
Co-expression experiments: Express chicken KCNG2 with potential partner subunits in heterologous systems
FRET or BiFC assays to confirm physical interaction
Electrophysiological characterization of co-expressed channels compared to homomeric channels
Co-immunoprecipitation studies to verify subunit associations in native tissues
Expected Functional Effects: Heteromeric assembly may alter:
Voltage-dependence of activation/inactivation
Gating kinetics
Current density
Pharmacological sensitivity
Trafficking and surface expression
Regulation by intracellular signaling pathways
Researchers should systematically test combinations with other Kv channels expressed in the same tissues and document the resulting functional parameters in comparative data tables.
Studying KCNG2 trafficking and membrane insertion requires multiple complementary approaches:
Fluorescent Protein Tagging: Generate fusion constructs of chicken KCNG2 with fluorescent proteins (GFP, mCherry) at positions that don't interfere with trafficking signals or channel function, typically at the C-terminus.
Live Cell Imaging Techniques:
Confocal microscopy for subcellular localization
TIRF microscopy to visualize membrane insertion events
FRAP (Fluorescence Recovery After Photobleaching) to assess mobility and turnover rates
Pulse-chase experiments with photo-convertible fluorescent proteins
Surface Biotinylation Assays: Quantify surface expression under various conditions using cell-impermeant biotinylation reagents followed by streptavidin pulldown and Western blotting.
Electrophysiological Correlation: Combine imaging with patch-clamp recordings to correlate trafficking events with functional channel expression.
Trafficking Pathway Interference:
Use temperature blocks (15-20°C) to arrest trafficking at specific cellular compartments
Apply pharmacological inhibitors of specific trafficking pathways
Express dominant-negative forms of trafficking regulators (Rab GTPases, SNARE proteins)
Analysis of Trafficking Motifs: Perform site-directed mutagenesis of potential ER retention, export, or endocytic signals within the KCNG2 sequence and assess effects on localization.
This multimodal approach provides comprehensive understanding of the dynamic processes governing KCNG2 surface expression in avian cells.
Post-translational modifications (PTMs) often critically regulate ion channel function. For chicken KCNG2:
Key PTMs to Investigate:
Phosphorylation (PKA, PKC, CaMKII sites)
Ubiquitination
SUMOylation
Glycosylation
Palmitoylation
Identification Methods:
Mass spectrometry of purified chicken KCNG2 to map PTM sites
Computational prediction of consensus sequences for various modifications
In vitro assays with purified kinases/enzymes
Functional Assessment:
Site-directed mutagenesis of predicted PTM sites
Electrophysiological assessment of mutants
Pharmacological manipulation of modifying enzymes during patch-clamp recordings
Biochemical assessment of modification state after various stimuli
Temporal Dynamics: Pulse-chase experiments to determine the sequence and timing of modifications during channel maturation and trafficking.
Signaling Pathway Integration: Investigate how extracellular signals and intracellular second messengers regulate these modifications in native avian tissues or primary cultures.
| Potential PTM Type | Predicted Effect on KCNG2 | Investigation Method |
|---|---|---|
| Phosphorylation | Modulation of voltage sensitivity, activation/inactivation kinetics | Site-directed mutagenesis, in vitro kinase assays, phospho-specific antibodies |
| Glycosylation | Affects trafficking, membrane stability, and possibly drug interactions | Treatment with glycosidases, mutation of N-glycosylation sites, lectin binding assays |
| Ubiquitination | Controls channel turnover and degradation rates | Ubiquitination assays, proteasome inhibitors, mutational analysis of lysine residues |
| SUMOylation | May affect channel trafficking and protein-protein interactions | SUMO-site mutations, in vitro SUMOylation assays |
| Palmitoylation | Potentially regulates membrane microdomain localization | Acyl-biotin exchange chemistry, 2-bromopalmitate treatment, mutation of cysteine residues |
Understanding species differences in KCNG2 is critical for translational research:
Sequence Comparison: Perform comprehensive alignments of chicken KCNG2 with mammalian orthologs, focusing on:
Core transmembrane domains (likely highly conserved)
Voltage-sensor region (S4 segment)
Pore domain (selectivity filter)
Intracellular regulatory domains (higher likelihood of species differences)
N- and C-terminal regions (often show greatest divergence)
Structural Analysis:
Generate homology models based on available crystal structures of related potassium channels
Use molecular dynamics simulations to predict functional differences
Analyze differences in protein-protein interaction motifs
Functional Comparison:
Side-by-side electrophysiological characterization of chicken and mammalian KCNG2
Cross-species pharmacological profiling
Comparison of modulation by intracellular signaling pathways
While specific data on chicken KCNG2 is limited in the provided search results, researchers should approach this by applying methodologies similar to those used for other ion channels. Based on patterns seen with related potassium channels, expect most significant differences in regulatory domains and mechanisms rather than in core channel functions.
For developmental studies of chicken KCNG2, several experimental systems offer unique advantages:
Chicken Embryo Model:
In ovo electroporation for targeted gene delivery
CRISPR/Cas9-mediated genome editing in early embryos
Tissue-specific viral transduction
Ex ovo cultivation for easier manipulation and imaging
Primary Culture Systems:
Neuron cultures from embryonic chicken brain regions
Chicken cardiac myocyte cultures
Organ slice cultures maintaining tissue architecture
Temporal Expression Analysis:
Staged collection of embryonic tissues for qRT-PCR and Western blotting
RNAscope for high-sensitivity detection of KCNG2 transcripts in tissue sections
Temporal transcriptomics across developmental stages
Functional Assessment:
Patch-clamp electrophysiology of developing neurons/myocytes
Calcium imaging to assess indirect effects of KCNG2 modulation
Multi-electrode arrays for network-level analyses
Gene Manipulation Approaches:
Morpholino knockdown for transient suppression
Dominant-negative constructs
Inducible expression systems for temporal control
The chicken embryo model is particularly valuable as it allows direct observation and manipulation of developing tissues in a system that is accessible, cost-effective, and ethically preferable to mammalian models for many developmental studies.
Reconstitution of functional chicken KCNG2 in artificial membranes presents significant technical challenges but offers powerful analytical capabilities:
Protein Expression and Purification:
Use insect cell (Sf9/Sf21) expression systems with baculovirus vectors for higher yields of functional eukaryotic membrane proteins
Include affinity tags (His, FLAG) for purification while ensuring they don't interfere with function
Solubilize with mild detergents (DDM, CHAPS) that maintain protein structure
Consider nanodiscs or amphipols for maintaining native-like environment during purification
Membrane System Selection:
Planar lipid bilayers for detailed electrophysiological measurements
Liposomes for ensemble functional assays
Giant unilamellar vesicles (GUVs) for fluorescence-based assays
Supported lipid bilayers for surface-sensitive techniques
Lipid Composition Optimization:
Test various phospholipid mixtures (PC, PE, PS, PI)
Include cholesterol at physiological ratios
Consider native lipid extracts from chicken neural membranes
Systematically vary membrane fluidity and charge
Functional Verification Methods:
Potassium flux assays using fluorescent indicators
Electrical recordings across reconstituted membranes
Conformational changes using spectroscopic methods
Co-reconstitution Considerations:
Include relevant accessory subunits or interacting proteins
Reconstitute with components of signaling pathways for studying regulation
This approach allows isolation of intrinsic channel properties from cellular context and enables precise manipulation of the lipid environment to study lipid-protein interactions.
CRISPR/Cas9 approaches offer powerful tools for studying chicken KCNG2 function:
Guide RNA Design:
Target early exons to ensure functional disruption
Use chicken-specific genome databases for accurate sequence information
Employ multiple bioinformatics tools to predict off-target sites
Design multiple gRNAs for each target to increase success rates
Consider the PAM requirements specific to the Cas9 variant being used
Delivery Methods for Chicken Models:
In ovo electroporation for embryonic studies
Lentiviral vectors for stable integration
Lipofection of cultured primary cells
Ribonucleoprotein (RNP) complex delivery for transient editing
Editing Strategies:
Knockout: Single gRNA for frameshift mutations
Precise modification: Homology-directed repair with donor templates
Domain-specific alterations: Target conserved functional domains
Conditional systems: Combine with Cre-loxP for temporal/spatial control
Validation Methods:
T7E1 or Surveyor assays for initial editing efficiency assessment
Deep sequencing for comprehensive mutation analysis
Western blotting to confirm protein disruption
Electrophysiological assessment of channel function
Phenotypic Analysis:
Tissue-specific effects on excitability
Developmental consequences
Compensation by other potassium channels
Behavioral assessments for neural function
When designing CRISPR experiments for chicken KCNG2, researchers should carefully consider developmental timing, as early disruption might lead to compensatory expression of other channels that could mask phenotypes.
Chicken models of KCNG2 function can provide valuable insights into neurological disorders:
Advantages of Chicken Models:
Developmental accessibility for neural studies
Closer evolutionary relationship to mammals than other non-mammalian models
Well-characterized nervous system
Cost-effective compared to mammalian models
Ethical advantages for early-stage drug screening
Modeling Approaches:
CRISPR/Cas9 gene editing to introduce human disease mutations
Overexpression of mutant channels using viral vectors
Pharmacological manipulation with subtype-specific channel blockers
Electrophysiological characterization of neuronal excitability
Relevant Neurological Conditions:
Epilepsy syndromes
Neurodevelopmental disorders
Movement disorders
Neuropathic pain conditions
Episodic neurological disorders
Translational Applications:
Drug screening platforms for potassium channel modulators
Target validation for therapeutic development
Mechanistic studies in an accessible vertebrate system
Comparative Analyses:
Side-by-side testing of human and chicken channels with identical mutations
Cross-species validation of therapeutic approaches
Identification of conserved regulatory mechanisms
While direct study of chicken KCNG2 in disease contexts is limited in the current literature, the established methodologies for studying potassium channels in chicken models provide a foundation for developing these translational applications.
The pharmacological modulation of chicken KCNG2 represents an important area for research:
Classes of Potassium Channel Modulators to Investigate:
Pore blockers (TEA, 4-AP derivatives)
Gating modifiers (retigabine-like compounds)
Peptide toxins (from venomous animals)
Small molecule activators
Lipophilic modulators acting at protein-lipid interfaces
Methodological Approach:
Electrophysiological screening in heterologous expression systems
Comparison with mammalian KCNG2 pharmacology
Structure-activity relationship studies
Binding site identification through mutagenesis
In silico docking and molecular dynamics simulations
Species-Specific Considerations:
Potentially unique pharmacological properties due to sequence differences
Differential sensitivity to modulators compared to mammalian channels
Possible novel binding sites or mechanisms
Applications:
Development of selective tools for chicken KCNG2 research
Cross-species validation of therapeutic approaches
Identification of conserved drug binding pockets
Systematic pharmacological profiling of chicken KCNG2 would provide valuable tools for further research and potentially identify novel modulatory mechanisms applicable across species.
High-throughput approaches offer significant advantages for KCNG2 research:
Automated Patch-Clamp Platforms:
Implementation with recombinant cell lines expressing chicken KCNG2
Optimization of cell preparation protocols for consistent recordings
Validation against conventional patch-clamp recordings
Development of standardized voltage protocols optimized for KCNG2 properties
Application Areas:
Pharmacological screening of compound libraries
Mutagenesis studies to map functional domains
Comparative analysis with mammalian orthologs
Interaction studies with potential auxiliary subunits
Data Analysis Considerations:
Automated quality control metrics
Standardized analysis pipelines for activation/inactivation parameters
Machine learning approaches for pattern recognition in large datasets
Integration with structural and computational data
Technical Challenges:
Optimization of expression levels for reliable recordings
Potential artifacts from cell line models
Balancing throughput with data quality
Adapting protocols for heteromeric channels
While high-throughput platforms may sacrifice some data quality compared to conventional methods, the ability to rapidly test multiple conditions and compounds makes this an invaluable approach for comprehensive characterization of chicken KCNG2.
Computational approaches provide powerful tools for understanding KCNG2:
Homology Modeling:
Using crystal structures of related potassium channels as templates
Refinement with molecular dynamics simulations
Validation through experimental testing of predictions
Special attention to modeling the voltage-sensor and pore domains
Molecular Dynamics Simulations:
Analysis of conformational changes during gating
Ion permeation studies
Lipid-protein interactions in membrane environment
Drug binding simulations
Machine Learning Applications:
Prediction of functional effects of mutations
Classification of pharmacological sensitivity
Pattern recognition in electrophysiological data
Integration of diverse experimental datasets
Systems Biology Approaches:
Network modeling of KCNG2 interactions
Prediction of regulatory pathways
Multi-scale modeling linking molecular function to cellular effects
Specific Tools and Resources:
MODELLER, I-TASSER, or AlphaFold2 for structure prediction
GROMACS or NAMD for molecular dynamics
Specialized force fields for membrane proteins
PyMOL or Chimera for structural visualization and analysis
These computational approaches can guide experimental design and provide mechanistic insights difficult to obtain through experimental methods alone.
Several cutting-edge technologies show particular promise:
Cryo-EM for Structural Studies:
Potential for high-resolution structures of chicken KCNG2 in different conformational states
Visualization of heteromeric assemblies
Structural basis of pharmacological interactions
Technical challenges in expression and purification of sufficient quantities
Optogenetic and Chemogenetic Approaches:
Development of light-activated or chemically-activated KCNG2 variants
Precise temporal control of channel activity in specific cell populations
Integration with calcium imaging for network-level analyses
Applications in developmental and functional studies
Single-Cell Transcriptomics and Proteomics:
Mapping cell type-specific expression patterns
Correlation of KCNG2 with other channels and regulatory proteins
Developmental trajectories of expression
Identification of cell populations for targeted functional studies
Advanced Imaging Technologies:
Super-resolution microscopy for nanoscale localization
Single-molecule tracking of channel movements
FRET sensors for conformational changes
Correlative light and electron microscopy
Genome Engineering Beyond CRISPR:
Base editing for precise nucleotide changes
Prime editing for targeted insertions or deletions
Epigenetic editing to modulate expression
Conditional approaches for temporal control
These technologies can provide unprecedented insights into KCNG2 biology and establish chicken models as valuable systems for ion channel research.
Multi-omics integration offers comprehensive insights into KCNG2 regulation:
Combined Approaches:
Genomics: Identification of regulatory elements and genetic variants
Transcriptomics: Expression patterns across tissues and developmental stages
Proteomics: Protein abundance, modifications, and interactions
Metabolomics: Effects on cellular metabolism and signaling molecules
Electrophysiomics: Functional correlates of molecular findings
Integration Strategies:
Network analysis to identify regulatory hubs
Machine learning for pattern recognition across datasets
Correlation analyses between omics layers
Causal inference methods to establish regulatory relationships
Experimental Design Considerations:
Temporal sampling across development
Cell type-specific analyses where possible
Perturbation studies to establish causality
Cross-species comparative analyses
Expected Outcomes:
Comprehensive regulatory network controlling KCNG2 expression
Identification of post-transcriptional and post-translational mechanisms
Contextual understanding of channel function in different cellular environments
Novel therapeutic targets for diseases involving potassium channel dysfunction
This integrated approach moves beyond reductionist methods to understand KCNG2 function in its full biological context.